Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
11/2010
11/09/2010CA2620891C Use of n-(dibenz (b,f) oxepin-10ylmethyl)-n-methyl-n-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy
11/09/2010CA2484188C Tachykinin receptor antagonists
11/09/2010CA2315953C 3'-epimeric k-252a derivatives
11/04/2010WO2010126167A1 Thiophene derivative
11/04/2010WO2010126104A1 4-substituted pyridazinone compound and p2x7 receptor inhibitor
11/04/2010WO2010125799A1 Urea derivative having pi3k inhibitory activity
11/04/2010WO2010125348A1 Prevention and treatment of sarcopenia
11/04/2010WO2010125271A1 Use of n2o gas for treating chronic pain
11/04/2010WO2010124520A1 Pharmaceutical composition for treating abnormal energy metabolism and use thereof
11/04/2010WO2010124365A1 Compositions and methods for modulating stem cells and uses thereof
11/04/2010WO2010068264A3 Novel formulations to inhibit cyclooxygenase and pro-inflammatory cytokine mediated diseases
11/04/2010US20100281547 Selecting animals for desired genotypic or potential phenotypic properties
11/04/2010US20100280094 Compositions and methods to treat muscular & cardiovascular disorders
11/04/2010US20100280074 Ccr9 inhibitors and methods of use thereof
11/04/2010US20100279992 Use of lanostane and poria extract in treating cachexia
11/04/2010US20100279958 Compounds and methods for inhibiting selectin-mediated function
11/04/2010US20100279953 Non-protein stabilized clostridial toxin pharmaceutical compositions
11/04/2010US20100279945 High-potency botulinum toxin formulations
11/04/2010US20100279406 Alteration of tumor growth using zinc finger proteins
11/04/2010US20100278901 Compositions and methods of making rapidly dissolving ionically masked formulations
11/04/2010CA2760387A1 Thiophene derivative
11/04/2010CA2760133A1 Treatment of neurodegeneration and neuroinflammation
11/04/2010CA2760042A1 Compositions and methods for modulating stem cells and uses thereof
11/04/2010CA2755780A1 Use of n2o gas for treating chronic pain
11/03/2010EP2246053A1 Use of pramipexole to treat amyotrophic lateral sclerosis
11/03/2010EP1159457B1 T cell receptor vbeta - dbeta - jbeta) sequence and methods for its detection
11/03/2010CN1951390B Pharmaceutical compositions comprising colloidal silicon dioxide
11/03/2010CN101874846A Method for preparing cataplasm for treating soft tissue injury
11/02/2010US7825129 Thieno[2,3-c] isoquinolines for use as inhibitors of PARP
11/02/2010US7824683 Methods for augmenting an immune response using anti-CD40 antibodies
11/02/2010CA2389491C Spiro(2h-1-benzopyran-2,4'-piperidine) derivates as glycine transport inhibitors
10/2010
10/28/2010WO2010123243A2 Composition containing a testis extract for treating or preventing diseases
10/28/2010WO2010121324A1 A novel formulation of metaxalone
10/28/2010WO2010081070A3 Novel forms of eperisone
10/28/2010WO2010075287A3 Compounds and methods for the treatment of pain and other diseases
10/28/2010US20100273862 Phosphatases which activate map kinase pathways
10/28/2010US20100272754 Botulinum toxin administration to treat various conditions
10/28/2010US20100272737 Novel Peptides and Protein and Uses Thereof
10/28/2010US20100272734 Compositions and methods for increasing muscle growth
10/28/2010US20100272718 Antibodies Against Human NKG2D and Uses Thereof
10/28/2010US20100272685 Porcine Adeno-Associated Viruses
10/28/2010CA2759113A1 A novel formulation of metaxalone
10/27/2010EP1432408B1 Pharmaceutical compositions comprising colloidal silicon dioxide
10/27/2010EP1218509B9 Fibroblast growth factor-like polypeptides
10/27/2010CN1585633B Phenethanolamine derivatives for treatment of respiratory diseases
10/27/2010CN101869672A Moxibustion liquid and preparation process thereof
10/27/2010CN101869565A Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
10/26/2010US7820814 Inhibitors of kinases
10/26/2010US7820717 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
10/26/2010US7820161 Treatment of autoimmune diseases
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2412164C Amidine derivatives as selective antagonists of nmda receptors
10/26/2010CA2304700C Lipophilic diesters of chelating agents
10/21/2010WO2010121225A2 Method of treating disorders associated with protein kinase ck2 activity
10/21/2010WO2010119875A1 Fused pyrrolopyridine derivative
10/21/2010WO2010118699A1 High purified (2β,3α,5α,16β,17β) -2-(4-morpholinyl)-16-(1-pyrrolidinyl)-androstane-3,17-diol or composition containing it and its preparation method
10/21/2010WO2010118675A1 New use of neferine
10/21/2010US20100268329 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
10/21/2010US20100268321 Drug-releasing graft
10/21/2010US20100267794 Anti-fatigue agent comprising amino acid composition
10/21/2010US20100267753 Methods of treating disorders associated with protein kinase ck2 activity
10/21/2010US20100267633 N-(4-Oxo-3,4-Dihydroquinazolin-2Yl) Butanamides as Androgen Receptor Modulators
10/21/2010US20100267620 Methods for slowing senescence and treating and preventing diseases associated with senescence
10/21/2010US20100266551 Adeno-associated viral vectors for the expression of dysferlin
10/21/2010CA2758359A1 Fused pyrrolopyridine derivative
10/20/2010EP2241575A1 Methods of treating obesity with combination therapeautics of igf-1 fusion polypeptides
10/20/2010EP1747778B1 Anti-fatigue composition
10/20/2010EP1722798B1 Pyrimidine compounds as purine receptor antagonists
10/20/2010EP1206554B2 Activatable recombinant neurotoxins
10/20/2010CN101863948A High-purity (2 beta, 3 alpha, 5 alpha, 16 beta, 17 beta)-2-(4-morpholinyl)-16-(1-pyrrolidinyl)-androstane-3,17-diol or composition thereof and preparation method thereof
10/20/2010CN101863917A Methocarbamol salt
10/19/2010US7816398 Fatty alcohol drug conjugates
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816358 Pharmaceutical formulations comprising N,N′-disubstituted piperazine compounds
10/19/2010CA2448089C Thiolalkyl benzoic acid derivatives
10/19/2010CA2390526C Sequence specific dna recombination in eukaryotic cells
10/14/2010WO2010116673A1 Mitochondrial function-improving agent
10/14/2010US20100261271 Regulation of endogenous gene expression in cells using zinc finger proteins
10/14/2010US20100260716 Compounds for treating demyelination conditions
10/14/2010US20100260668 Dual Variable Domain Immunoglobulins and Uses Thereof
10/14/2010DE102009016719A1 Composition, useful as pharmaceutical preparation for e.g. prophylaxis of lipid metabolic disorders in humans and animals and treating atherosclerosis, comprises 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor and solid material
10/14/2010CA2758189A1 Tricyclo-dna antisense oligonucleotides, compositions, and methods for the treatment of disease
10/13/2010CN101856326A Method for preparing medical lycorine emulsion
10/12/2010CA2480038C Substituted 4-aminocyclohexanols
10/12/2010CA2445512C A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method
10/12/2010CA2382317C Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010113225A1 Riluzole-containing transdermal patch
10/07/2010WO2010112093A1 Benzoxazoles for the treatment of duchenne muscular dystrophy
10/07/2010WO2010112092A1 Compounds for treatment of duchenne musculary dystrophy
10/07/2010WO2010112091A1 Compounds for treatment of duchenne muscular dystrophy
10/07/2010WO2010081862A3 Methods and preparations for protecting critically ill patients with a polyamine (e.g. spermine, spermidine)
10/07/2010US20100256174 External preparation composition comprising fatty acid-based ionic liquid as active ingredient
10/07/2010US20100256141 Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
10/07/2010US20100256111 Therapeutic agents useful for treating pain
10/07/2010US20100256085 Toll-Like Receptor Agonist Regulation of VEGF-Induced Tissue Responses
10/07/2010US20100255537 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
10/07/2010US20100255112 Efficient Nuclear Delivery of Antisense Oligonucleotides or siRNA In Vitro and In Vivo by Nano-Transforming Polymersomes
10/07/2010US20100255013 Glycoprotein compositions
10/07/2010US20100254990 Anti-ngf antibodies for the treatment of various disorders
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 233